Join
Live feed
·
PRReleasevia Quantisnow
Onconova Therapeutics Inc. logo

Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update

ByQuantisnow·Wall Street's wire, on your screen.
ONTX· Onconova Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONTX (Onconova Therapeutics Inc.) and more on Quantisnow.